Algorae Pharmaceuticals Limited

OTCPK:LVCL.F Stock Report

Market Cap: US$8.0m

Algorae Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Algorae Pharmaceuticals has a total shareholder equity of A$3.0M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$3.2M and A$178.4K respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$3.11m
EquityAU$3.01m
Total liabilitiesAU$178.45k
Total assetsAU$3.19m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: LVCL.F's short term assets (A$3.2M) exceed its short term liabilities (A$178.4K).

Long Term Liabilities: LVCL.F has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: LVCL.F is debt free.

Reducing Debt: LVCL.F has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LVCL.F has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: LVCL.F has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 9.8% each year.


Discover healthy companies